跳至主要内容
临床试验/NCT02118519
NCT02118519已完成2 期

Use of Mesenchymal Stem Cells for the Repair of Articular Cartilage Disorder of Knee Using Intra-articular Injection of Mesenchymal Cells Alone or Mesenchymal Cells With Platelet Lysate

University of Jordan1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2014年1月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
13
试验地点
1
主要终点
Assessing the therapeutic benefits of the injected Autologous Mesenchymal Stem Cells.

研究概览

简要总结

Induction of autologous repair chondrogenesis to regenerate injured articular cartilage using bone marrow mesenchymal stem cells (MSCs) after in vitro expansion under restricted culturing conditions.

详细描述

Fourteen patients from both genders, age range 40-68, will be enrolled according to strict inclusion and exclusion criteria, divided into two equal groups based upon receiving autologous MSCs alone, or MSCs supported by platelet lysate through percutaneous injection.

The patients are followed by clinical assessment, laboratory investigations as well as magnetic resonance imaging (MRI) of the injected knee.

The investigators hypothesize that the two groups will give satisfactory clinical outcomes, but the investigators are looking forward to assessing the best product that will activate chondrogenesis and heal cartilaginous injury.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
40 Years 至 68 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •MRI must show moderate/severe articular injury
  • •Serum collagen II must be above the normal value.
  • •Lesion site: Femoral and Tibial condyles or patella
  • •Admission of steroid , NSAID, pain killers must be stopped before 1 month

排除标准

  • •Lesion size
  • •PT and PTT not within normal value
  • •Complete blood count ( Hb, PCV, and RBC) not within the normal value
  • •HIV and Hepatitis Antigens (B and C) detection

研究组 & 干预措施

mesenchymal stem cells

Active Comparator

Autologous Mesenchymal Stem Cells primed prior to intra articular injection into knees of patients with advanced articular cartilage injury

干预措施: Autologous Mesenchymal Stem Cells (Biological)

mesenchymal cells&platelet lysate

Active Comparator

Autologous Mesenchymal Stem Cells primed prior to intra articular injection with platelet lysate into knees of patients with advanced articular cartilage injury

干预措施: Autologous Mesenchymal Stem Cells (Biological)

结局指标

主要结局

Assessing the therapeutic benefits of the injected Autologous Mesenchymal Stem Cells.

时间窗: 12 months

次要结局

  • Assessment of the articular cartilage healing in osteoarthritic patients through intra articular injection of Autologus Mesenchymal stem cell with/or without supported product.(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fatima Jamali

Researcher

University of Jordan

研究点 (1)

Loading locations...

相似试验

Mesenchymal Stem Cells in Knee Cartilage Injuries | 临床试验